OLTIPRAZ CAS 64224-21-1: Potent Tumor Prevention Agent and Phase II Detoxification Enzyme Inducer
Discover the potent chemopreventive capabilities of OLTIPRAZ, a key inducer of vital detoxification enzymes.
Get a Quote & SampleProduct Core Value
OLTIPRAZ
OLTIPRAZ is a powerful synthetic agent recognized for its significant role in tumor prevention. It is a potent inducer of Phase II detoxification enzymes, most notably glutathione-S-transferase (GST), which are crucial for the body's defense against harmful substances and carcinogens.
- Unlock the potential of OLTIPRAZ for tumor prevention, offering a novel approach in health research.
- Leverage OLTIPRAZ as a key inducer of Phase II detoxification enzymes, supporting cellular protective mechanisms.
- Explore the scientific advancements in OLTIPRAZ's application for cancer chemoprevention, a critical area of medical research.
- Investigate the synthetic dithiolethione's role in promoting cellular health, aligning with modern wellness trends.
Key Advantages Offered
Enhanced Chemopreventive Activity
OLTIPRAZ's proven efficacy in tumor prevention makes it a valuable asset for researchers and developers in the pharmaceutical and health sectors.
Potent Enzyme Induction
As a strong inducer of glutathione-S-transferase (GST), OLTIPRAZ bolsters the body's natural detoxification pathways, a critical factor in overall health maintenance.
Versatile Research Applications
From studying cancer mechanisms to exploring new therapeutic targets, OLTIPRAZ serves as a vital tool in various biomedical research fields.
Key Applications
Tumor Prevention Research
Investigate the chemopreventive properties of OLTIPRAZ in preclinical and clinical studies, aiming to develop new strategies against cancer.
Detoxification Enzyme Studies
Utilize OLTIPRAZ to explore the induction and function of Phase II detoxification enzymes, understanding their role in health and disease.
Pharmaceutical Intermediate
As a high-purity fine chemical, OLTIPRAZ can serve as a crucial intermediate in the synthesis of novel pharmaceutical compounds.
Antischistosomal Agent Research
Explore the historical use and potential renewed interest in OLTIPRAZ as an antischistosomal agent, given its unique chemical structure.